David Manzella, PT in Orchard Park, NY - Medicare Physical Therapy Provider

David Manzella, PT is a medicare enrolled "Physical Therapist" provider in Orchard Park, New York. He graduated from medical school in 1991 and has 33 years of diverse experience with area of expertise as Physical Therapy. He is a member of the group practice Duchscherer Physical Therapy Pllc and his current practice location is 4 Centre Dr Ste G, Orchard Park, New York. You can reach out to his office (for appointments etc.) via phone at (716) 662-2922.

David Manzella is licensed to practice in New York (license number 12209) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1194863621.

Contact Information

	David Manzella, PT
	4 Centre Dr Ste G, Orchard Park, NY 14127-4117
	(716) 662-2922
	(716) 662-3828

Healthcare Provider's Profile

Full Name	David Manzella
Gender	Male
Speciality	Physical Therapy
Experience	33 Years
Location	4 Centre Dr Ste G, Orchard Park, New York
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

David Manzella graduated from medical school in 1991

NPI Data:

NPI Number: 1194863621
Provider Enumeration Date: 02/05/2007
Last Update Date: 03/01/2022

Medicare PECOS Information:

PECOS PAC ID: 0941476345
Enrollment ID: I20120106000374

Medical Identifiers

Medical identifiers for David Manzella such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194863621	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	12209 (New York)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Duchscherer Physical Therapy Pllc	1759768161	5

News Archive

Valproic acid halts vision loss in patients with retinitis pigmentosa

Researchers at the University of Massachusetts Medical School believe they may have found a new treatment for retinitis pigmentosa, a severe neurodegenerative disease of the retina that ultimately results in blindness. One of the more common retinal degenerative diseases, RP is caused by the death of photoreceptor cells and affects 1 in 4,000 people in the United States. RP typically manifests in young adulthood as night blindness or a loss of peripheral vision and in many cases progresses to legal blindness by age 40.

Rituxan's sBLA receives a Complete Response from the FDA

Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.

FDA sets new PDUFA date for AstraZeneca's ticagrelor

AstraZeneca announced today that the US Food and Drug Administration (FDA) has acknowledged receipt of the company's reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA).

Combination of genetic mutation and viral infection may cause prostate cancer

Significant recent interest in the literature (JAMA 2006;295:1503, Lancet, epub) and by patients has arisen in response to a presentation given by Dr. Eric Klein of the Cleveland Clinic at the 2006 Prostate Cancer Symposium in San Francisco, February 24, 2006.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. David Manzella allows following entities to bill medicare on his behalf.

Provider Name	Duchscherer Physical Therapy Pllc
Provider Type	Part B Supplier - Physical/occupational Therapy Group In Private Practice
Provider Identifiers	NPI Number: 1144849670 PECOS PAC ID: 1759768161 Enrollment ID: O20220524000971

News Archive

Valproic acid halts vision loss in patients with retinitis pigmentosa

Rituxan's sBLA receives a Complete Response from the FDA

FDA sets new PDUFA date for AstraZeneca's ticagrelor

Combination of genetic mutation and viral infection may cause prostate cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Manzella is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Manzella, PT 4 Centre Dr Ste G, Orchard Park, NY 14127-4117 Ph: (716) 662-2922	David Manzella, PT 4 Centre Dr Ste G, Orchard Park, NY 14127-4117 Ph: (716) 662-2922

News Archive

Valproic acid halts vision loss in patients with retinitis pigmentosa

Rituxan's sBLA receives a Complete Response from the FDA

FDA sets new PDUFA date for AstraZeneca's ticagrelor

Combination of genetic mutation and viral infection may cause prostate cancer

Physical Therapist in Orchard Park, NY

Sharon Held, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3940 California Rd, Orchard Park, NY 14127 Phone: 716-662-2922 Fax: 716-662-3828
Ms. Tina Miller, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3690 Southwestern Blvd, Orchard Park, NY 14127 Phone: 716-662-4955 Fax: 716-972-0338
Mr. Gregory Phillip Thompson, PT, MS, GCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Saddlebrook Ct, Orchard Park, NY 14127 Phone: 716-863-0345 Fax: 716-662-0020
Riley Marion, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6167 W Quaker St, Orchard Park, NY 14127 Phone: 716-662-4800
Ms. Wendy Lisa Barrett, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6098 Seufert Rd, Orchard Park, NY 14127 Phone: 716-923-3014
Jamie L Phelan, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6055 Armor Duells Rd, Orchard Park, NY 14127 Phone: 716-662-5544
Charles Geary, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3940 California Rd, Orchard Park, NY 14127 Phone: 716-662-2922 Fax: 716-662-3828

David Manzella, PT - Medicare Physical Therapist in Orchard Park, NY

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Valproic acid halts vision loss in patients with retinitis pigmentosa

Rituxan's sBLA receives a Complete Response from the FDA

FDA sets new PDUFA date for AstraZeneca's ticagrelor

Combination of genetic mutation and viral infection may cause prostate cancer

Medicare Reassignments

Valproic acid halts vision loss in patients with retinitis pigmentosa

Rituxan's sBLA receives a Complete Response from the FDA

FDA sets new PDUFA date for AstraZeneca's ticagrelor

Combination of genetic mutation and viral infection may cause prostate cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Valproic acid halts vision loss in patients with retinitis pigmentosa

Rituxan's sBLA receives a Complete Response from the FDA

FDA sets new PDUFA date for AstraZeneca's ticagrelor

Combination of genetic mutation and viral infection may cause prostate cancer

Physical Therapist in Orchard Park, NY